Health
Researchers Seek Hepatitis B Cure as Trump Slashes Health Agency Funding
The Trump administration’s efforts to slash medical research funding threaten progress toward a cure for hepatitis B. Its proposed budget calls for $1.8 billion in cuts to the National Institutes of Health and the elimination of all federal funding for the National Institute on Minority Health and Health Disparities, along with additional cuts to the Food and Drug Administration, which has final say on approving new drugs and treatments. The cuts are just the latest in a series of hurdles that researchers and clinicians face in managing hepatitis B infections in the United States.